 |
|
HIV Infection Stems From Few Viruses
May 16, 2008BIRMINGHAM, Ala. - A new study reveals the genetic identity of human immunodeficiency virus (HIV), the version responsible for sexual transmission, in unprecedented detail.
The finding provides important clues in the ongoing search for an effective HIV/AIDS vaccine, said researchers at the University of Alabama at Birmingham (UAB). The UAB team found that among billions of HIV variants only a few lead to sexual transmission.
Earlier studies have shown that a 'bottleneck' effect occurs where few versions of the virus lead to infection while many variants are present in the blood. The UAB study is the first to use genetic analysis and mathematical modeling to identify precisely those viruses responsible for HIV transmission.
George M. Shaw, M.D., Ph.D., professor in the UAB departments of Medicine and Microbiology and senior author on the report, said the research sheds new light on potential vulnerabilities in the virus at a time when science, medicine and society are still reeling from the failure of a major HIV vaccine clinical trial.
"We can now identify unambiguously those viruses that are responsible for sexual transmission of HIV-1. For the first time we can see clearly the face of the enemy," said Shaw, a project leader with the Center for HIV/AIDS Vaccine Immunology. The center is a National Institutes of Health-sponsored consortium of researchers at UAB, Harvard Medical School in Boston, Oxford University in England, the University of North Carolina in Chapel Hill and Duke University in Durham, N.C.
The new HIV-1 findings are published online in the Proceedings of the National Academy of Sciences.
The new study was performed by sequencing many copies of the HIV envelope gene present in the viruses taken from 102 recently infected patients. The envelope gene encodes for a protein called Env that forms part of the outer covering of the virus, and is responsible for its infectiousness.
The researchers then used sophisticated mathematical models of HIV replication and genetic change to identify the virus or viruses responsible for transmission. In 80 percent of the newly infected patients, a single virus caused transmission, though each virus was different in each patient. In the other 20 percent of patients, two to five unique viruses caused transmission.
"Previously, researchers employed inexact methodologies that prevented precise identification of the virus that initiated infection," said Brandon Keele, Ph.D., an instructor in UAB's Department of Medicine and lead study investigator. "Our findings allow us to identify not only the transmitted virus, but also viruses that evolve from it."
The UAB team said their work would lead to new research on how different HIV genes and proteins work together to make a virus biologically fit for transmission and for growth in the face of mounting immunity.
Statistics show that while the worldwide percentage of people infected with HIV has leveled off, the total number HIV cases is rising. In 2007, 33.2 million people were estimated to be living with HIV, 2.5 million people became newly infected and 2.1 million people died from AIDS, according to the Joint United Nations Programme on HIV/AIDS (UNAIDS) and the World Health Organization.
The new study was sponsored by grants from the National Institute of Allergy and Infectious Diseases and the Bill and Melinda Gates Foundation. It was conducted by researchers in the UAB departments of Medicine and Microbiology, at Duke University, Los Alamos National Laboratory and the Santa Fe Institute in New Mexico, the University of Massachusetts in Amherst, the University of North Carolina, Chapel Hill, the University of Maryland in College Park, the University of California, San Francisco, the University of Rochester in New York and the University of Cape Town in Rondebosch, South Africa.
University of Alabama at Birmingham
George M. Shaw, M.D., Ph.D., professor in the UAB departments of Medicine and Microbiology and senior author on the report, said the research sheds new light on potential vulnerabilities in the virus at a time when science, medicine and society are still reeling from the failure of a major HIV vaccine clinical trial.
"We can now identify unambiguously those viruses that are responsible for sexual transmission of HIV-1. For the first time we can see clearly the face of the enemy," said Shaw, a project leader with the Center for HIV/AIDS Vaccine Immunology. The center is a National Institutes of Health-sponsored consortium of researchers at UAB, Harvard Medical School in Boston, Oxford University in England, the University of North Carolina in Chapel Hill and Duke University in Durham, N.C.
The new HIV-1 findings are published online in the Proceedings of the National Academy of Sciences.
The new study was performed by sequencing many copies of the HIV envelope gene present in the viruses taken from 102 recently infected patients. The envelope gene encodes for a protein called Env that forms part of the outer covering of the virus, and is responsible for its infectiousness.
The researchers then used sophisticated mathematical models of HIV replication and genetic change to identify the virus or viruses responsible for transmission. In 80 percent of the newly infected patients, a single virus caused transmission, though each virus was different in each patient. In the other 20 percent of patients, two to five unique viruses caused transmission.
"Previously, researchers employed inexact methodologies that prevented precise identification of the virus that initiated infection," said Brandon Keele, Ph.D., an instructor in UAB's Department of Medicine and lead study investigator. "Our findings allow us to identify not only the transmitted virus, but also viruses that evolve from it."
The UAB team said their work would lead to new research on how different HIV genes and proteins work together to make a virus biologically fit for transmission and for growth in the face of mounting immunity.
Statistics show that while the worldwide percentage of people infected with HIV has leveled off, the total number HIV cases is rising. In 2007, 33.2 million people were estimated to be living with HIV, 2.5 million people became newly infected and 2.1 million people died from AIDS, according to the Joint United Nations Programme on HIV/AIDS (UNAIDS) and the World Health Organization.
The new study was sponsored by grants from the National Institute of Allergy and Infectious Diseases and the Bill and Melinda Gates Foundation. It was conducted by researchers in the UAB departments of Medicine and Microbiology, at Duke University, Los Alamos National Laboratory and the Santa Fe Institute in New Mexico, the University of Massachusetts in Amherst, the University of North Carolina, Chapel Hill, the University of Maryland in College Park, the University of California, San Francisco, the University of Rochester in New York and the University of Cape Town in Rondebosch, South Africa.
University of Alabama at Birmingham
HIV Infection News and Current HIV Infection Events RSSRisk of fracture is significantly higher in HIV-infected patients
As antiviral treatment for HIV infection allows patients to live longer, many will be confronted with additional health challenges. A new study shows for the first time that one of these may be significantly increased risk of bone fractures.
NIAID describes challenges, prospects for an HIV vaccine
Events of the past year in HIV vaccine research have led some to question whether an effective HIV vaccine will ever be developed. In the August 28 edition of the New England Journal of Medicine, officials from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, examine the extraordinarily challenging properties of the virus that have made a vaccine elusive and outline the scientific questions that, if answered, could lead to an effective HIV vaccine.
Study reveals gap in HIV testing knowledge among college students
Most college students understand how they can prevent the transmission of HIV but are less knowledgeable about HIV testing, according to a new University of Georgia study.
India continues to progress in AIDS vaccine development efforts
A second Phase I AIDS vaccine clinical trial in India was successfully completed, the Indian Council of Medical Research, the National AIDS Control Organization and the International AIDS Vaccine Initiative announced. The results of the trial of an MVA-based AIDS vaccine candidate (TBC-M4), which was conducted in Chennai, indicated that the vaccine candidate had acceptable levels of safety and was well tolerated.
Women in India abused by husbands at far greater risk for HIV infection
India is home to the third-largest number of human immunodeficiency virus (HIV) cases in the world and, as in the U.S. and many African nations, the rate of infection among women continues to rise faster than that among men.
Black girls who use marijuana engage in riskier sex, have higher STD rate
Black girls who use marijuana are more likely to engage in risky sexual acts and contract a sexually transmitted disease, a new study finds.
Novel method to create personalized immunotherapy treatments
Argos Therapeutics and Université de Montréal today announced the presentation of new information on Argos'process for developing dendritic cell-based immunotherapies for HIV.
Male circumcision efforts lag in Africa despite evidence of dramatic impact in preventing HIV
With millions of lives at stake over the next two decades, researchers and advocates at the AIDS 2008 Conference today called on the global health community to ramp up male circumcision to significantly reduce risk of HIV infection in Africa, and to move quickly to integrate the life-saving procedure into other comprehensive efforts to prevent transmission of the disease in the vulnerable nations of eastern and southern Africa.
New Male Circumcision Device for HIV Prevention Studied by NewYork-Presbyterian/Weill Cornell
With the recent endorsement by the World Health Organization (WHO) and scientists worldwide of adult male circumcision as an important strategy for HIV prevention, there is increased urgency to develop safe and cost-effective circumcision services. This is especially the case in Africa where HIV/AIDS continues to spread at an epidemic rate.
Growth hormone reduces abdominal fat, cardiovascular risk in HIV patients on antiviral therapy
Low-dose growth hormone treatment reduced abdominal fat deposits and improved blood pressure and triglyceride levels in a group of patients with HIV lipodystrophy, a condition involving the redistribution of fat and other metabolic changes in patients receiving combination drug therapy for HIV infection.
More HIV Infection News Articles
 | The First Year: HIV: An Essential Guide for the Newly Diagnosed (First Year, The) by Brett Grodeck This supportive resource explores the next generation of HIV/AIDS drugs and also includes new research on HIV and crystal meth, as well as new insights for the hardest hit population — African... |
 | HIV/AIDS: A Very Short Introduction (Very Short Introductions) by Alan Whiteside HIV/AIDS is without doubt the worst epidemic to hit humankind since the Black Death. As of 2004 an estimated 40 million people were living with the disease, and about 20 million had died. Despite rapid scientific advances there is still no cure and the drugs are expensive and toxic. In the developing world, especially in parts of Africa, life expectancy has plummeted to below 35 years, causing... |
 | Inventing the AIDS Virus by Peter H. Duesberg Duesberg argues that HIV is merely a harmless passenger virus that does not cause... |
 | Witches, Westerners, And HIV: AIDS And Cultures of Blame in Africa by Alexander Rodlach |
 | 100 Questions and Answers About HIV and AIDS by Joel Gallant 100 Questions and Answers about HIV and AIDS provides answers to the most common questions asked by people with HIV and AIDS, their partners, and their family members. Written by an internationally recognized HIV expert from Johns Hopkins University with commentary by two HIV-positive patients, this is an invaluable resource for people with HIV infection or for those who care about them. It... |
 | AIDS in the Twenty-First Century, Fully Revised and Updated Edition: Disease and Globalization by Tony Barnett, Alan Whiteside First published in 2002, AIDS in the Twenty-First Century met with widespread praise from researchers and policy makers. This edition is fully revised to take account of the latest facts and developments in the field. All statistics and evidence have been updated and their meanings reconsidered. Latest developments in vaccines, anti-retroviral treatments and microbicides are discussed along with... |
 | The Guide to Living with HIV Infection: Developed at the Johns Hopkins AIDS Clinic (A Johns Hopkins Press Health Book) by John G. Bartlett, Ann K. Finkbeiner The Guide to Living with HIV Infection is the most complete source of medical, emotional, social, and practical advice available for those infected with HIV and their loved ones. Developed at the Johns Hopkins AIDS Clinic, the guide provides essential information for making decisions about treatment and testing in a world transformed by new research and pharmacotherapy.In this thoroughly updated... |
 | Geography Of The Heart by Fenton Johnson In 1990, Larry Rose, the partner of novelist Fenton Johnson, died of complications from AIDS. In Geography of the Heart, Fenton, author of Scissors, Paper, Rock, Songs of the Soil, and Crossing the River, honors Rose with a beautifully written memoir. Alternating between his own story and Rose's as far back as childhood, Johnson fashions a moving portrait of the man who was "a teacher, [who]... |
 | The Origin, Persistence and Failings of HIV/AIDS Theory by Henry H. Bauer Thanks to enormous funding for educational programs, the whole world "knows" that HIV causes AIDS. But is what we know compatible with the facts? This book challenges the conventional wisdom on this issue. Collating and analyzing, for the first time, the results of more than two decades of HIV testing, it reveals that the common assumptions about HIV and AIDS are incompatible with the published... |
 | Basic Infection Control for Healthcare Providers by Michael Kennamer Basic Infection Control for Health Care Providers, Second Edition, is a clear and concise guide to preventing occupational exposure hazards and communicable and infectious diseases. This book includes coverage on how to safely protect oneself from infectious agents and what do in case of infectious exposure. Discussions of the disease process and legal issues surrounding exposure and infectious... |
| © 2008 BrightSurf.com |